These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27027942)

  • 1. Severe Asthma in Pediatric Patients. Pathophysiology and Unmet Needs.
    Dunn R; Szefler SJ
    Ann Am Thorac Soc; 2016 Mar; 13 Suppl 1():S103-4. PubMed ID: 27027942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.
    National Asthma Education and Prevention Program
    J Allergy Clin Immunol; 2007 Nov; 120(5 Suppl):S94-138. PubMed ID: 17983880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Gossage D; Tran TN
    J Allergy Clin Immunol Pract; 2014; 2(6):741-50. PubMed ID: 25439366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of asthma and chronic obstructive pulmonary disease: current status and future perspectives.
    Ambrosino N; Paggiaro P
    Expert Rev Respir Med; 2012 Feb; 6(1):117-27. PubMed ID: 22283584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The exacerbation component of impairment and risk in pediatric asthma.
    Bloomberg GR
    Curr Opin Allergy Clin Immunol; 2010 Apr; 10(2):155-60. PubMed ID: 20010093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society.
    Beveridge RC; Grunfeld AF; Hodder RV; Verbeek PR
    CMAJ; 1996 Jul; 155(1):25-37. PubMed ID: 8673983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
    Green RH; Brightling CE; McKenna S; Hargadon B; Parker D; Bradding P; Wardlaw AJ; Pavord ID
    Lancet; 2002 Nov; 360(9347):1715-21. PubMed ID: 12480423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe asthma: advances in current management and future therapy.
    Barnes PJ
    J Allergy Clin Immunol; 2012 Jan; 129(1):48-59. PubMed ID: 22196524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-interleukin-5 antibody therapy in asthma and allergies.
    Corren J
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):565-70. PubMed ID: 21971335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in pediatric asthma in 2014: Moving toward a population health perspective.
    Szefler SJ
    J Allergy Clin Immunol; 2015 Mar; 135(3):644-52. PubMed ID: 25649079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory biomarkers in severe asthma.
    Chung KF
    Curr Opin Pulm Med; 2012 Jan; 18(1):35-41. PubMed ID: 22045348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National surveillance for asthma--United States, 1980-2004.
    Moorman JE; Rudd RA; Johnson CA; King M; Minor P; Bailey C; Scalia MR; Akinbami LJ;
    MMWR Surveill Summ; 2007 Oct; 56(8):1-54. PubMed ID: 17947969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma.
    Wagener AH; de Nijs SB; Lutter R; Sousa AR; Weersink EJ; Bel EH; Sterk PJ
    Thorax; 2015 Feb; 70(2):115-20. PubMed ID: 25422384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What goes up must come down: biomarkers and novel biologicals in severe asthma.
    Hilvering B; Pavord ID
    Clin Exp Allergy; 2015 Jul; 45(7):1162-9. PubMed ID: 25640208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Unmet need in asthma management and future treatment options].
    Gillissen A
    Pneumologie; 2015 Jan; 69(1):36-45; quiz 46-7. PubMed ID: 25599141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary lysis of eosinophils in severe desquamative asthma.
    Persson C
    Clin Exp Allergy; 2014 Feb; 44(2):173-83. PubMed ID: 24330324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
    Chung KF
    J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in pediatric asthma in 2011: moving forward.
    Szefler SJ
    J Allergy Clin Immunol; 2012 Jan; 129(1):60-8. PubMed ID: 22196525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies to reduce asthma exacerbations.
    O'Byrne PM
    J Allergy Clin Immunol; 2011 Aug; 128(2):257-63; quiz 264-5. PubMed ID: 21531015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.